Literature DB >> 4021312

Increased bone aluminum deposition after subtotal parathyroidectomy in dialyzed patients.

M C de Vernejoul, S Marchais, G London, C Morieux, J Bielakoff, L Miravet.   

Abstract

Ten dialyzed patients underwent a systematic bone biopsy before and 19 +/- 9 months after subtotal parathyroidectomy (PTX). At the end of the follow-up period all the patients, except two, who complained of proximal myalgia, were asymptomatic. Compared to the bone biopsy specimen obtained prior surgery, decreased bone formation without mineralization impairment was observed after PTX. Despite an average decrease in aluminum gels intake after PTX, an increase in stained aluminum was observed (0.69 +/- 0.79 versus 1.20 +/- 0.95 mm/mm2, P less than 0.050). Aluminum accumulation depended on the pre-PTX bone aluminum load: pre- and post-PTX bone aluminum loads were correlated (r = 0.78, P less than 0.01). Bone aluminum accumulation was not related to the amount of aluminum gel intake after PTX; however, only two patients free of both bone aluminum deposit prior to PTX and aluminum gel intake after PTX had no stainable aluminum on the second bone biopsy after PTX. The only patient who had no decrease in bone formation after PTX had no increase in bone aluminum. Assuming that the patients had no aluminum deposit prior to dialysis, we measured the rate of bone aluminum accumulation. It rose from 0.11 +/- 0.09 mm/mm2/year prior to PTX to 0.40 +/- 0.25 mm/mm2/year after PTX (P less than 0.05) in the six patients who were maintained on phosphate binders and who had a decrease in bone formation after PTX. These six patients had unchanged aluminum gel intake.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4021312     DOI: 10.1038/ki.1985.81

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Impairment of bone formation with aluminum and ferric nitrilotriacetate complexes.

Authors:  Y Ebina; S Okada; S Hamazaki; Y Toda; O Midorikawa
Journal:  Calcif Tissue Int       Date:  1991-01       Impact factor: 4.333

3.  Differential diagnosis between secondary hyperparathyroidism and aluminum intoxication in uremic patients: usefulness of 99mTc-pyrophosphate bone scintigraphy.

Authors:  P Kinnaert; I Van Hooff; A Schoutens; P Bergmann; M Fuss; M Dratwa; A Vienne; J L Pasteels; J van Geertruyden; J L Vanherweghem
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

4.  Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.

Authors:  Gérard M London; Sylvain J Marchais; Alain P Guérin; Pierre Boutouyrie; Fabien Métivier; Marie-Christine de Vernejoul
Journal:  J Am Soc Nephrol       Date:  2008-05-14       Impact factor: 10.121

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.